Viveca Ritsinger

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: CARDIOVASCULAR DIABETOLOGY. 2024;23(1):290
Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
Ritsinger V; Avander K; Lagerqvist B; Lundman P; Norhammar A
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024;84(3):260-272
Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus
Santos-Pardo I; Franko MA; Lagerqvist B; Ritsinger V; Eliasson B; Witt N; Norhammar A; Nystrom T
Article: JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2023;37(10):108599
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
Ritsinger V; Hagstrom E; Hambraeus K; James S; Jernberg T; Lagerqvist B; Leosdottir M; Lundman P; Pernow J; Ostlund O; Norhammar A
Article: BMJ OPEN. 2023;13(4):e069037
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study
Ritsinger V; Bodegard J; Kristofi R; Thuresson M; Nathanson D; Nystrom T; Eriksson J; Norhammar A
Article: CARDIOVASCULAR DIABETOLOGY. 2022;21(1):282
Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data
Kristofi R; Bodegard J; Ritsinger V; Thuresson M; Nathanson D; Nystrom T; Norhammar A; Eriksson JW
Article: CARDIOVASCULAR DIABETOLOGY. 2022;21(1):129
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
Meziani S; Ferrannini G; Bjerre M; Hansen TK; Ritsinger V; Norhammar A; Gyberg V; Nasman P; Ryden L; Mellbin LG
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2021;10(22):e022667
Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes
Ritsinger V; Hagstrom E; Lagerqvist B; Norhammar A
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2021;330:23-29
Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study
Santos-Pardo I; Lagerqvist B; Ritsinger V; Witt N; Norhammar A; Nystrom T
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2020;17(6):1479164120973676
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
Ritsinger V; Lagerqvist B; Lundman P; Hagstrom E; Norhammar A
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2020;27(17):1890-1901
Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry
Ritsinger V; Nystrom T; Saleh N; Lagerqvist B; Norhammar A
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2019;16(6):582-584
Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART study
Ritsinger V; Jensen J; Ohm D; Omerovic E; Koul S; Frobert O; Erlinge D; James S; Lagerqvist B; Norhammar A
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2018;15(6):511-518
Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction
Wang A; Arver S; Flanagan J; Gyberg V; Nasman P; Ritsinger V; Mellbin LG
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2018;15(5):387-395
Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort
Ritsinger V; Brismar K; Mellbin L; Nasman P; Ryden L; Soderberg S; Norhammar A
Article: DIABETES CARE. 2018;41(4):876-883
Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry Report
Ritsinger V; Hero C; Svensson A-M; Saleh N; Lagerqvist B; Eeg-Olofsson K; Norhammar A
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2017;24(8):848-857
Mortality and extent of coronary artery disease in 2776 patients with type 1 diabetes undergoing coronary angiography: A nationwide study
Ritsinger V; Hero C; Svensson AM; Saleh N; Lagerqvist B; Eeg-Olofsson K; Norhammar A
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2017;14(2):69-76
Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort
Smaradottir MI; Ritsinger V; Gyberg V; Norhammar A; Nasman P; Mellbin LG
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2017;14(2):77-87
Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort
Ritsinger V; Brismar K; Malmberg K; Mellbin L; Nasman P; Ryden L; Soderberg S; Tenerz A; Norhammar A
Article: CIRCULATION: CARDIOVASCULAR INTERVENTIONS. 2015;8(6):e002328
High Event Rate After a First Percutaneous Coronary Intervention in Patients With Diabetes Mellitus Results From the Swedish Coronary Angiography and Angioplasty Registry
Ritsinger V; Saleh N; Lagerqvist B; Norhammar A
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2015;12(1):23-32
Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: Longterm follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort
Ritsinger V; Tanoglidi E; Malmberg K; Nasman P; Ryden L; Tenerz A; Norhammar A
Article: THE LANCET DIABETES AND ENDOCRINOLOGY. 2014;2(8):627-633
Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial
Ritsinger V; Malmberg K; Martensson A; Ryden L; Wedel H; Norhammar A

Alla övriga publikationer

Thesis / dissertation: 2016
Causes and mechanisms of an adverse outcome in patients with glucose abnormalities and cardiovascular disease : epidemiological and biochemical analyses
Ritsinger, Viveca

Anställningar

Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2016
Läkarexamen, Karolinska Institutet, 2007

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI